HesperadinはオーロラBを有効に抑制して、無細胞試験でIC50値が250 nMになって、AMPK、Lck、MKK1、MAPKAP-K1、CHK1とPHKの活性を著しく下げますが、体内でMKK1活性を抑制しないことです。

価格 在庫  
USD 214 あり
USD 403 あり
USD 441 あり
USD 1222 あり
電話番号: + 81 3-5632-9610mail@cosmobio.co.jp

Hesperadin 化学構造
分子量: 516.65





  • Compare Aurora Kinase Inhibitors
    Aurora Kinase製品生物活性の比較
  • 研究分野
  • Hesperadinのメカニズム



製品説明 HesperadinはオーロラBを有効に抑制して、無細胞試験でIC50値が250 nMになって、AMPK、Lck、MKK1、MAPKAP-K1、CHK1とPHKの活性を著しく下げますが、体内でMKK1活性を抑制しないことです。
ターゲット Aurora B (human) TbAUK1
IC50 250 nM [1] 40 nM [2]
In vitro試験 Hesperadin inhibits the ability of immunoprecipitated Aurora B to phosphorylate histone H3 with IC50 of 250 nM and markedly reduces the activity of other kinases (AMPK, Lck, MKK1, MAPKAP-K1, CHK1, and PHK) at a concentration of 1 μM. In contrast, only 20-100 nM of Hesperadin is sufficient to induce the loss of mitotic histone H3-Ser10 phosphorylation in HeLa cells. Hesperadin treatment causes defects in mitosis and cytokinesis, leading to stoppage of proliferation of HeLa cells and polyploidization, which can be specifically ascribed to the inhibition of Aurora B function during the process of chromosome attachment. Hesperadin (100 nM) quickly overrides the mitotic arrest induced by taxol or monastrol but not by nocodazole. Hesperadin and nocodazole treatment in HeLa cells abolishes kinetochore localization of BubR1 and diminishes the intensity of Bub1 at kinetochores, suggesting that Aurora B function is required for efficient kinetochore recruitment of BubR1 and Bub1, which in turn might be necessary for prolonged checkpoint signaling. [1] Hesperadin prevents the phosphorylation of recombinant trypanosome histone H3 by the T. brucei Aurora kinase-1 (TbAUK1) from pathogenic Trypanosoma brucei with IC50 of 40 nM in vitro kinase assays. Hesperadin significantly inhibits cell growth of cultured infectious bloodstream forms (BF) with IC50 of 48 nM, and only weakly inhibits cell growth of insect stage procyclic forms (PF) with IC50 of 550 nM. [2]
In vivo試験

プロトコル (参考用のみ)

キナーゼアッセイ: [1]

The Aurora B kinase assay For the Aurora B kinase assay, HeLa cells are lysed in a buffer containing 50 mM NaCl. The whole cell extract is spun at 13,000 rpm for 20 minutes at 4 °C using a table top centrifuge. The pellet obtained from 200 mg of whole cell extract is extracted again in 15 mL lysis buffer containing 250 mM NaCl in order to obtain active Aurora B kinase from mitotic chromatin. The low speed supernatant of the latter extract is used for immunoprecipitation. Monoclonal mouse anti–AIM-1, or mouse anti-HA, is coupled to GammaBind Plus Sepharose, and beads are rotated over-end in the extract for 90 minutes at 4 °C. Beads are washed, aliquoted, and washed in kinase buffer (20 mM Tris, pH 7.5, 150 mM NaCl, 10 mM MgCl2, 1 mM DTT, 10 mM NaF). The kinase assay is performed with 10 μL beads in 20 μL kinase buffer containing 5 μg histone H3, 10 μM ATP, 2.5 μCi [γ-32P]ATP, and different concentrations of Hesperadin for 20 minutes at 37 °C. SDS sample buffer is added, and samples are boiled and resolved by SDS-PAGE. The gel is dried, and the radioactive signal is detected by PhosphorImager analysis. The data is analyzed using ImageQuant software.

細胞アッセイ: [1]

細胞株 HeLa cells and PtK1 cells
濃度 Final concentration ~500 nM
反応時間 24 and 48 hours
実験の流れ Cells are exposed to different concentrations of Hesperadin for 24 and 48 hours. At indicated time points, methanol-fixed cell samples are washed with PBS and subsequently stained in PI buffer (50 μg/mL propidium iodide, 10 mM Tris, pH 7.5, 5 mM MgCl2, 200 μg/mL RNase A) for 20-40 minutes at 37 °C. The DNA content is determined by flow cytometry.

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDogMonkeyBaboon
Weight (kg)
Body Surface Area (m2)0.0070.0250.
Km factor361285201220
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)



Download Hesperadin SDF
分子量 516.65


CAS No. 422513-13-1
保管 3年-20℃
2年-80℃in solvent
別名 N/A
溶解度 (25°C) * In vitro DMSO 103 mg/mL (199.36 mM)
Water <1 mg/mL
Ethanol <1 mg/mL
In vivo 30% PEG400+0.5% Tween80+5% propylene glycol 30 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
化学名 (Z)-N-(2-oxo-3-(phenyl(4-(piperidin-1-ylmethyl)phenylamino)methylene)indolin-5-yl)ethanesulfonamide

文献中の引用 (12)



電話番号: +1-832-582-8158 Ext:3月曜日〜金曜日 9:00 AM–5:00 PM (米国中部標準時)


* 必須

Related オーロラ・キナーゼ 阻害剤

  • Ro-3306

    RO-3306 is an ATP-competitive, and selective CDK1 inhibitor with Ki of 20 nM, >15-fold selectivity against a diverse panel of human kinases.

  • CCG-1423

    CCG-1423 is a specific RhoA pathway inhibitor, which inhibits SRF-mediated transcription.

  • ML141

    ML141 is a potent, selective and reversible non-competitive inhibitor of Rho family GTPase cdc42 with IC50 of 200 nM.

  • Salirasib

    Salirasib is a potent competitive prenylated protein methyltransferase (PPMTase) inhibitor with Ki of 2.6 μM, which inhibits Ras methylation. Phase 2.

  • Alisertib (MLN8237)

    Alisertib (MLN8237)は一種の選択性オーロラ(Aurora )A阻害剤で、無細胞試験でIC50値が1.2 nMです。Alisertib (MLN8237)はオーロラAに作用する選択性はオーロラ Bに作用する選択性より200倍以上が高くなります。臨床3期。

    Features:First orally available inhibitor of Aurora A.

  • Barasertib (AZD1152-HQPA)

    Barasertib (AZD1152-HQPA)は一種の高度選択性のオーロラ B阻害剤で、無細胞試験でIC50値が0.37 nMです。Barasertib (AZD1152-HQPA)はオーロラ Bに作用する選択性はオーロラAに作用する選択性より3700左右倍が高くなります。臨床1期。

  • VX-680 (Tozasertib, MK-0457)

    VX-680 (Tozasertib, MK-0457) は一種のパンーオーロラ(pan-Aurora)阻害剤です。VX-680 (Tozasertib, MK-0457) はオーロラAに作用する効果が一番強くて、無細胞試験でKiapp値が0.6 nMになりますが、オーロラ B/オーロラCに作用する効果が少し弱くて、且つオーロラAに作用する選択性は他の55種キナーゼに作用する選択性より100倍がそれぞれ高くなります。臨床2期。

  • Danusertib (PHA-739358)

    Danusertib (PHA-739358)は一種のオーロラキナーゼ阻害剤です。Danusertib (PHA-739358)はオーロラA/B/Cに作用して、無細胞試験でIC50値が13 nM/79 nM/61 nMになリますが、Abl、TrkA、c-RETとFGFR1に適度に作用します。Danusertib (PHA-739358)はLck、VEGFR2/3、c-KitとCDK2等に作用する効果が少し弱いです。臨床2期。

  • ZM 447439

    ZM 447439は一種の選択性的で、ATP競争性的なオーロラAとオーロラ Bの阻害剤で、IC50値が110 nMと130 nMです。ZM 447439は、オーロラA/オーロラ Bに作用する選択性はMEK1、 SrcとLckに作用する選択性より8倍がそれぞれ高くなりますが、CDK1/2/4、Plk1とChk1等に作用する効果が殆どありません。

    Features:An Aurora selective ATP-competitive inhibitor.

  • MLN8054

    MLN8054は一種の有効的で、選択性的なオーロラA阻害剤で、Sf9昆虫細胞でIC50値が4 nMです。MLN8054は、オーロラAに作用する選択性はオーロラ Bに作用する選択性より40倍が高くなります。臨床1期。


Tags: Hesperadinを買う | Hesperadin供給者 | Hesperadinを購入する | Hesperadin費用 | Hesperadin生産者 | オーダーHesperadin | Hesperadin代理店
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID